Technical Analysis for FREQ - Frequency Therapeutics, Inc.

Grade Last Price % Change Price Change
grade D 15.44 1.31% 0.20
FREQ closed up 1.31 percent on Friday, December 6, 2019, on approximately normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals

ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A N/A Down
See historical FREQ trend table...

Date Alert Name Type % Chg
NR7 Range Contraction 0.00%
NR7-2 Range Contraction 0.00%
Stochastic Reached Oversold Weakness 0.00%
Oversold Stochastic Weakness 0.00%
NR7 Range Contraction 1.31%
Inside Day Range Contraction 1.31%
Down 3 Days in a Row Weakness 1.31%
20 DMA Resistance Bearish -0.77%
Bearish Engulfing Bearish -1.91%
Fell Below 20 DMA Bearish -1.91%

Older signals for FREQ ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Frequency Therapeutics is a clinical-stage biotechnology company focused on harnessing the body’s innate biology to repair or reverse damage caused by a broad range of degenerative diseases. Frequency’s progenitor cell activation (PCA) approach stimulates progenitor cells to create functional tissue with the aim of developing disease modifying therapeutics. The company’s lead product candidate, FX-322, is in clinical development and is designed to regenerate auditory hair cells to restore hearing function in patients with sensorineural hearing loss, the most common form of hearing loss. The company is also evaluating its PCA approach in additional diseases, including multiple sclerosis.
Biotechnology Medical Specialties Disease Multiple Sclerosis Occupational Safety And Health Perception Degenerative Diseases Hearing Loss Audiology Auditory System Hearing Sensorineural Hearing Loss

Is FREQ a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 17.44
52 Week Low 11.17
Average Volume 112,801
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 15.90
10-Day Moving Average 16.08
Average True Range 0.99
ADX 17.64
+DI 15.21
-DI 18.15
Chandelier Exit (Long, 3 ATRs ) 14.47
Chandelier Exit (Short, 3 ATRs ) 17.25
Upper Bollinger Band 17.13
Lower Bollinger Band 14.66
Percent B (%b) 0.31
BandWidth 15.52
MACD Line 0.33
MACD Signal Line 0.54
MACD Histogram -0.2134
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 16.34
Resistance 3 (R3) 16.36 16.08 16.19
Resistance 2 (R2) 16.08 15.85 16.07 16.14
Resistance 1 (R1) 15.76 15.71 15.62 15.74 16.09
Pivot Point 15.48 15.48 15.41 15.47 15.48
Support 1 (S1) 15.16 15.25 15.02 15.14 14.79
Support 2 (S2) 14.88 15.11 14.87 14.74
Support 3 (S3) 14.56 14.88 14.69
Support 4 (S4) 14.54